Virpax Pharmaceuticals Stock Piotroski F Score
| VRPX Stock | USD 4.04 0.57 16.43% |
Virpax | Piotroski F Score |
At this time, it appears that Virpax Pharmaceuticals' Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
2.0
Piotroski F Score - Frail
| Current Return On Assets | Negative |
| Change in Return on Assets | Decreased |
| Cash Flow Return on Assets | Negative |
| Current Quality of Earnings (accrual) | Improving |
| Asset Turnover Growth | No Change |
| Current Ratio Change | Decrease |
| Long Term Debt Over Assets Change | Lower Leverage |
| Change In Outstending Shares | Increase |
| Change in Gross Margin | No Change |
Virpax Pharmaceuticals Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Virpax Pharmaceuticals is to make sure Virpax is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Virpax Pharmaceuticals' auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Virpax Pharmaceuticals' financial numbers are properly reported.
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Current Liabilities | 8.1 M | 7.7 M |
|
| |||||
| Total Assets | 12.7 M | 9.6 M |
|
| |||||
| Total Current Assets | 12.7 M | 9.6 M |
|
|
Virpax Pharmaceuticals F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Virpax Pharmaceuticals' different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Virpax Pharmaceuticals in a much-optimized way.
| -0.7 | 0.65 | -0.72 | 0.71 | 0.71 | -0.81 | ||
| -0.7 | -0.28 | 0.66 | -1.0 | -1.0 | 0.89 | ||
| 0.65 | -0.28 | -0.4 | 0.3 | 0.3 | -0.5 | ||
| -0.72 | 0.66 | -0.4 | -0.65 | -0.65 | 0.76 | ||
| 0.71 | -1.0 | 0.3 | -0.65 | 1.0 | -0.88 | ||
| 0.71 | -1.0 | 0.3 | -0.65 | 1.0 | -0.88 | ||
| -0.81 | 0.89 | -0.5 | 0.76 | -0.88 | -0.88 |
Click cells to compare fundamentals
About Virpax Pharmaceuticals Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.Book Value Per Share |
|
Virpax Pharmaceuticals Current Valuation Drivers
We derive many important indicators used in calculating different scores of Virpax Pharmaceuticals from analyzing Virpax Pharmaceuticals' financial statements. These drivers represent accounts that assess Virpax Pharmaceuticals' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Virpax Pharmaceuticals' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 34.1M | 32.3M | 40.2M | 7.3M | 3.7M | 3.6M | |
| Enterprise Value | 35.3M | 33.8M | 3.3M | (11.7M) | (5.4M) | (5.1M) |
About Virpax Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Virpax Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virpax Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virpax Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Virpax Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Virpax Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Virpax Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Virpax Pharmaceuticals Stock:Check out Virpax Pharmaceuticals Altman Z Score, Virpax Pharmaceuticals Correlation, Virpax Pharmaceuticals Valuation, as well as analyze Virpax Pharmaceuticals Alpha and Beta and Virpax Pharmaceuticals Hype Analysis. For more information on how to buy Virpax Stock please use our How to Invest in Virpax Pharmaceuticals guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Virpax Stock analysis
When running Virpax Pharmaceuticals' price analysis, check to measure Virpax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virpax Pharmaceuticals is operating at the current time. Most of Virpax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Virpax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virpax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Virpax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Directory Find actively traded commodities issued by global exchanges |
Is Virpax Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Virpax Pharmaceuticals. If investors know Virpax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Virpax Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (12.97) | Return On Assets (0.55) | Return On Equity (1.64) |
The market value of Virpax Pharmaceuticals is measured differently than its book value, which is the value of Virpax that is recorded on the company's balance sheet. Investors also form their own opinion of Virpax Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Virpax Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virpax Pharmaceuticals' market value can be influenced by many factors that don't directly affect Virpax Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virpax Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Virpax Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virpax Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.